AGA Clinical Practice Update on Interaction between Oral Direct-Acting Antivirals (DAAs) for Chronic Hepatitis C Infection and Hepatocellular Carcinoma: Expert Review

Posted on March 13, 2019 by Gastroenterology Journal
This entry was posted in News. Bookmark the permalink.